Watch FIFA World Cup 2026™

LIVE, FREE and EXCLUSIVE

Potentially life saving cancer drug added to Pharmaceutical Benefits Scheme

Patient Alison Beninati holds a box of Keytruda, a medication used to treat Hodgkins lymphoma. (AAP). (SBS)
Patient Alison Beninati holds a box of Keytruda, a medication used to treat Hodgkins lymphoma. (SBS) Source: AAP (SBS)

A potentially life-saving cancer medicine that patients must self-fund at a cost of more than 200-thousand dollars, is being made available on prescription. The move brings down the cost to less than forty-dollars, every three weeks. It's one of five new drugs added to the Pharmaceutical Benefits Scheme.


Published

Updated

By Adrian Arciuli

Presented by Branko Cvetojevic

Source: SBS



Share this with family and friends


A potentially life-saving cancer medicine that patients must self-fund at a cost of more than 200-thousand dollars, is being made available on prescription. The move brings down the cost to less than forty-dollars, every three weeks. It's one of five new drugs added to the Pharmaceutical Benefits Scheme.



Latest podcast episodes

Follow SBS Serbian

Download our apps

Listen to our podcasts

Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS

Serbian News

Stream now